A York-based supplier of laboratory instruments and consumables to the veterinary profession has been acquired by a medical products company listed on American stock exchange Nasdaq.
Quality Clinical Reagents & Trio Diagnostics, which has been in operation for more than 35 years, has been bought by Abaxis, a maker of point-of-care instruments and consumables for the medical, research and veterinary markets
Achim Henkel, managing director of Abaxis Europe, said: "After a long and successful cooperation with QCR & Trio Diagnostics as our distribution partner in the United Kingdom and Ireland, we now take direct market responsibility by closing on this acquisition.
"We welcome the highly motivated and experienced QCR & Trio employees as new members of the Abaxis team and we look forward to a strengthened operational structure."
Clint Severson, president and chief executive of Abaxis, added: "Our goal is to build and strengthen our presence in additional geographic markets to expand the growth potential of Abaxis into the future.
"Investing more in Europe, and other international markets, will be a focus going forward."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here